Ultragenyx Pharmaceutical (RARE) EBT Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,369.00 |
| Dec 31, 2025 | 5,066.00 |
| Sep 30, 2025 | -4,379.00 |
| Jun 30, 2025 | 3,944.00 |
| Mar 31, 2025 | -36,919.00 |
| Dec 31, 2024 | 35,677.00 |
| Sep 30, 2024 | -657.00 |
| Jun 30, 2024 | 6,749.00 |
| Mar 31, 2024 | -5,619.00 |
| Dec 31, 2023 | 6,193.00 |
| Sep 30, 2023 | -1,527.00 |
| Jun 30, 2023 | 1,578.00 |
| Mar 31, 2023 | -1,435.00 |
| Dec 31, 2022 | 11,498.00 |
| Sep 30, 2022 | -8,661.00 |
| Jun 30, 2022 | 1,317.00 |
| Mar 31, 2022 | -4,023.00 |
| Dec 31, 2021 | -6,044.00 |
| Sep 30, 2021 | 5,105.00 |
| Jun 30, 2021 | -364.00 |
| Mar 31, 2021 | -11,044.00 |
| Dec 31, 2020 | 5,797.00 |
| Sep 30, 2020 | -12,582.00 |
| Jun 30, 2020 | 36,838.00 |
| Mar 31, 2020 | -7,033.00 |
| Dec 31, 2019 | 18,047.00 |
| Sep 30, 2019 | -2,704.00 |
| Jun 30, 2019 | 12,147.00 |
| Mar 31, 2019 | 807.00 |
| Dec 31, 2018 | 20,082.00 |
| Sep 30, 2018 | -32,881.00 |
| Jun 30, 2018 | -69,505.00 |
| Mar 31, 2018 | 494,790.00 |
| Dec 31, 2017 | 3.53 Mn |
| Dec 31, 2016 | -136.66 Mn |
| Sep 30, 2016 | 27.64 Mn |